CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CRSP — CRISPR Therapeutics AG
CIK 884546
SAN FRANCISCO, CA
Position in CRSP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$57,694,429
+$8,252,598 QoQ
Shares Held
1,057,837
+1.8% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 521 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. CRSP ranks #33 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in CRSP
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,694,429 | 1,057,837 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $49,441,831 | 1,039,349 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $54,022,744 | 1,030,182 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $63,887,753 | 985,770 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $45,391,042 | 933,204 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $24,281,732 | 713,539 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $28,458,539 | 723,032 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $34,024,842 | 724,241 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $38,757,900 | 717,606 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $45,612,126 | 669,192 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $40,879,239 | 653,023 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $28,956,005 | 637,938 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $36,306,355 | 646,711 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $28,982,343 | 640,777 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $26,060,471 | 641,094 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $40,655,411 | 622,118 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,155,434 | 348,123 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,270,984 | 354,803 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||